Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
0.9310
Dollar change
+0.0141
Percentage change
1.54
%
Index- P/E- EPS (ttm)-0.73 Insider Own72.95% Shs Outstand166.40M Perf Week-4.00%
Market Cap154.92M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float45.01M Perf Month-2.63%
Enterprise Value160.47M PEG- EPS next Q- Inst Own0.05% Short Float0.22% Perf Quarter6.07%
Income-2.73M P/S- EPS this Y- Inst Trans0.01% Short Ratio0.50 Perf Half Y-91.65%
Sales0.00M P/B- EPS next Y- ROA-17.24% Short Interest0.10M Perf YTD7.09%
Book/sh-3.19 P/C430.33 EPS next 5Y- ROE-62.50% 52W High15.00 -93.79% Perf Year-91.32%
Cash/sh0.00 P/FCF- EPS past 3/5Y-175.18% - ROIC- 52W Low0.56 65.60% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility8.25% 7.49% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM-610.86% Oper. Margin- ATR (14)0.09 Perf 10Y-
Dividend Ex-DateFeb 13, 2023 Quick Ratio0.04 Sales Y/Y TTM- Profit Margin- RSI (14)38.79 Recom-
Dividend Gr. 3/5Y- - Current Ratio0.04 EPS Q/Q-1113.92% SMA20-4.34% Beta- Target Price-
Payout- Debt/Eq- Sales Q/Q- SMA50-8.97% Rel Volume0.27 Prev Close0.92
Employees2 LT Debt/Eq- Earnings- SMA200-88.06% Avg Volume198.52K Price0.93
IPODec 23, 2021 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume53,798 Change1.54%
Alps Group, Inc. operates as a biotechnology company that integrates research and development, medical services, and wellness solutions. The company focuses on creating a fair healthcare ecosystem, to make advance predictive, preventive, and precision medicine accessible and affordable. The company is headquartered in Kuala Lumpur, Malaysia.